| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | CN1505926A Scorpion breeding method in nature simulating condition |
| 06/23/2004 | CN1505925A Biological energy garter snake hatching method |
| 06/22/2004 | US6753456 Animal model for use in developing treatment for nicotine addiction and epilepsey |
| 06/22/2004 | US6753153 Markers for identification and isolation of pancreatic islet α and β progenitors |
| 06/19/2004 | CA2423904A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 06/17/2004 | WO2004051265A2 Fish disease models and uses thereof |
| 06/17/2004 | WO2004050898A2 Ampk pathway components |
| 06/17/2004 | WO2004050847A2 Modified antibodies stably produced in milk and methods of producing same |
| 06/17/2004 | WO2004050674A2 Methods and materials for modulating trpm2 |
| 06/17/2004 | WO2004050117A1 Proteins involved in the regulation of energy homeostasis |
| 06/17/2004 | WO2004050007A2 Mammalian bt-42 proteins involved in the regulation of energy homeostasis |
| 06/17/2004 | WO2004049794A2 Single chain antibodies produced in a transgenic mouse |
| 06/17/2004 | WO2004049793A1 Model animal of cognitive learning disability with the use of leukemia inhibitory factor and method of constructing the same |
| 06/17/2004 | WO2004044003A3 Use of edg2 receptor in an animal model of heart failure |
| 06/17/2004 | WO2004035775A3 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 06/17/2004 | WO2004031767A3 Prevention of primary sjögren’s syndrome by ica69 deficiency |
| 06/17/2004 | WO2004031233A9 Novel chemokine-like polypeptides |
| 06/17/2004 | WO2004016742A3 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 06/17/2004 | WO2003022228A3 Method for producing transgenic birds and fish |
| 06/17/2004 | WO2002079419A3 Identifying and characterizing genes |
| 06/17/2004 | US20040117867 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 06/17/2004 | US20040117866 Novel transgenic zebrafish, gene fragments and methods for producing transgenic zebrafish |
| 06/17/2004 | US20040117865 Transposon generated genetically engineered rodent for use as tool in clarifying gene function; gene therapy and transposon mediated transformation |
| 06/17/2004 | US20040117864 Stable transgenic cells comprising functional neuronal protein; gene transfer and pattern analysis; insect model for monitoring cancer signal transduction |
| 06/17/2004 | US20040117863 Preparing genetically engineered polypeptide for diagnosis and treatment of cell proliferative disorders; cancer therapy and tumor targeting |
| 06/17/2004 | US20040117862 Production of high levels of transgenic factor VII with engineered stability and its therapeutic uses |
| 06/17/2004 | US20040115704 Identifying, evaluating and characterizing activity of transcriptional control elements using expression vectors and/or reporter vectors providing kinetics of protein expression; drug screening and discovery |
| 06/17/2004 | US20040115681 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 06/17/2004 | US20040115656 Androgen receptor down-regulatory-associated proteins(ARDAPs) for use in reduction of transactivation activity of androgen receptors and treatment of tumors; gene expression inhibition and anticarcinogenic agents |
| 06/17/2004 | US20040112299 Incorporation of competitive effects in breeding program to increase performance levels and improve animal well being |
| 06/17/2004 | CA2508236A1 Ampk pathway components |
| 06/17/2004 | CA2507863A1 Methods and materials for modulating trpm2 |
| 06/17/2004 | CA2506734A1 Fish disease models and uses thereof |
| 06/17/2004 | CA2506629A1 Modified antibodies stably produced in milk and methods of producing same |
| 06/16/2004 | EP1428887A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 06/16/2004 | EP1428872A2 Tolerance-inducing thymus-bone marrow composite tissue construct and organ |
| 06/16/2004 | EP1428834A1 Ligands for flt3 receptors |
| 06/16/2004 | EP1427856A2 Fusion proteins useful for detecting analytes |
| 06/16/2004 | EP1427828A2 Random integration of a polynucleotide after in vivo linearization |
| 06/16/2004 | EP1427819A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
| 06/16/2004 | EP1427750A1 Modified transferrin fusion proteins |
| 06/16/2004 | EP1233679B1 Process for enhancing canine and feline reproductive performance |
| 06/16/2004 | CN1504200A Red-legged disease, curlworm disease ecotype, immunity and prevention and cure technique of eelworm |
| 06/16/2004 | CN1504082A Asexual cultivation method of male tussah |
| 06/16/2004 | CN1504081A Asexual cultivation method of female wood frog |
| 06/15/2004 | US6750327 Compositions and method for determining the presence of human PTTG peptide in a sample |
| 06/15/2004 | US6750056 Metal binding proteins and associated methods |
| 06/10/2004 | WO2004048606A2 Porcine polymorphisms and methods for detecting them |
| 06/10/2004 | WO2004048568A1 UTILIZATION OF mKank GENE IN CANTER THERAPY, CANER DETECTION AND DRUG DISCOVERY |
| 06/10/2004 | WO2004047634A1 Zebrafish assay |
| 06/10/2004 | WO2004047531A2 Protein production in transgenic avians using lentiviral system |
| 06/10/2004 | WO2004047530A1 Transgenic model expressing a prp gene homozygous for m129 |
| 06/10/2004 | WO2004047523A2 Microbial feedstock for filter feeding aquatic organisms |
| 06/10/2004 | WO2004032865A3 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2004013171A3 Multi-subunit protein production system in transgenic insect |
| 06/10/2004 | WO2003096799A3 Multiple closed nucleus breeding for swine production |
| 06/10/2004 | WO2003054188A3 Seminal vesicle tissue-specific promoters and uses thereof |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | US20040111763 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/10/2004 | US20040111758 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 06/10/2004 | US20040110708 Binary hybrid mutational vectors |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110225 Fluorescent proteins from aquatic species |
| 06/10/2004 | US20040110173 Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene |
| 06/10/2004 | CA2507469A1 Porcine polymorphisms and methods for detecting them |
| 06/10/2004 | CA2507241A1 Protein production in transgenic avians |
| 06/09/2004 | EP1425964A1 Rat highly sensitive to carcinogen |
| 06/09/2004 | EP1425410A2 Tumor marker and methods of use |
| 06/09/2004 | EP1425400A2 Method for producing transgenic animals |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425386A1 Methods for injecting avian eggs |
| 06/09/2004 | EP1425289A2 Novel nucleic acid and polypeptide molecules |
| 06/09/2004 | EP1292185A4 Models of chronic and acute inflammatory diseases |
| 06/09/2004 | CN1503844A Novel expression vectors |
| 06/09/2004 | CN1503623A Method for construction of clone embryo of mammal |
| 06/09/2004 | CN1502694A Development of clone of domestic animal used as mammary gland boireactor by means of Cre-LoxP site-specific targeting somatic cell |
| 06/09/2004 | CN1502231A Method for obtaining inbred line small size pig |
| 06/08/2004 | US6747187 Knockout mouse for the tumor suppressor gene ANX7 |
| 06/08/2004 | US6747130 Tenebrio antifreeze proteins |
| 06/08/2004 | US6746682 Biological control of horn flies |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046348A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | WO2004046320A2 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 06/03/2004 | WO2004045630A1 An application of bacteriophages in transplantation |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004024084A9 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 06/03/2004 | WO2004021781A3 Cryptophlebia leucotreta granulovirus (crlegv-sa) as a biological control agent |
| 06/03/2004 | WO2003089580A3 Cancer models |
| 06/03/2004 | WO2003062415A3 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002073188A9 Method for generating replacement cells and/or tissues |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106179 Comprises lyases enzymatic peptide for use in screening modulator for treatment and prevention of cardiovascular disorders |